Investigating socioeconomic disparities in lung cancer diagnosis, treatment and mortality: an Italian cohort study.
Diagnosis
Lung cancer
Mortality
Socioeconomic disparities
Treatment
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
07 Jun 2024
07 Jun 2024
Historique:
received:
10
01
2024
accepted:
03
06
2024
medline:
8
6
2024
pubmed:
8
6
2024
entrez:
7
6
2024
Statut:
epublish
Résumé
Lung cancer is one of the most lethal cancers worldwide and patient clinical outcomes seem influenced by their socioeconomic position (SEP). Since little has been investigated on this topic in the Italian context, our aim was to investigate the role of SEP in the care pathway of lung cancer patients in terms of diagnosis, treatment and mortality. This observational retrospective cohort study included patients discharged in the Lazio Region with a lung cancer diagnosis between 2014 and 2017. In the main analysis, educational level was used as SEP measure. Multivariate models, adjusted for demographic and clinical variables, were applied to evaluate the association between SEP and study outcomes, stratified for metastatic (M) and non-metastatic (NM) cancer. We defined a diagnosis as 'delayed' when patients received their initial cancer diagnosis after an emergency department admission. Access to advanced lung cancer treatments (high-cost, novel and innovative treatments) and mortality were investigated within the 24-month period post-diagnosis. Moreover, two additional indicators of SEP were examined in the sensitivity analysis: one focusing on area deprivation and the other on income-based exemption. A total of 13,251 patients were identified (37.3% with metastasis). The majority were males (> 60%) and over half were older than 70 years. The distribution of SEP levels among patients was as follow: 31% low, 29% medium-low, 32% medium-high and 7% high. As SEP increased, the risks of receiving a delayed diagnosis ((high vs low: M: OR = 0.29 (0.23-0.38), NM: OR = 0.20 (0.16-0.25)) and of mortality ((high vs low M: OR = 0.77 (0.68-0.88) and NM: 0.61 (0.54-0.69)) decreased. Access to advanced lung cancer treatments increased in accordance with SEP only in the M cohort (high vs low: M: OR = 1.57 (1.18-2.09)). The primary findings were corroborated by sensitivity analysis. Our study highlighted the need of public health preventive and educational programs in Italy, a country where the care pathway of lung cancer patients, especially in terms of diagnosis and mortality, appears to be negatively affected by SEP level.
Sections du résumé
BACKGROUND
BACKGROUND
Lung cancer is one of the most lethal cancers worldwide and patient clinical outcomes seem influenced by their socioeconomic position (SEP). Since little has been investigated on this topic in the Italian context, our aim was to investigate the role of SEP in the care pathway of lung cancer patients in terms of diagnosis, treatment and mortality.
METHODS
METHODS
This observational retrospective cohort study included patients discharged in the Lazio Region with a lung cancer diagnosis between 2014 and 2017. In the main analysis, educational level was used as SEP measure. Multivariate models, adjusted for demographic and clinical variables, were applied to evaluate the association between SEP and study outcomes, stratified for metastatic (M) and non-metastatic (NM) cancer. We defined a diagnosis as 'delayed' when patients received their initial cancer diagnosis after an emergency department admission. Access to advanced lung cancer treatments (high-cost, novel and innovative treatments) and mortality were investigated within the 24-month period post-diagnosis. Moreover, two additional indicators of SEP were examined in the sensitivity analysis: one focusing on area deprivation and the other on income-based exemption.
RESULTS
RESULTS
A total of 13,251 patients were identified (37.3% with metastasis). The majority were males (> 60%) and over half were older than 70 years. The distribution of SEP levels among patients was as follow: 31% low, 29% medium-low, 32% medium-high and 7% high. As SEP increased, the risks of receiving a delayed diagnosis ((high vs low: M: OR = 0.29 (0.23-0.38), NM: OR = 0.20 (0.16-0.25)) and of mortality ((high vs low M: OR = 0.77 (0.68-0.88) and NM: 0.61 (0.54-0.69)) decreased. Access to advanced lung cancer treatments increased in accordance with SEP only in the M cohort (high vs low: M: OR = 1.57 (1.18-2.09)). The primary findings were corroborated by sensitivity analysis.
CONCLUSIONS
CONCLUSIONS
Our study highlighted the need of public health preventive and educational programs in Italy, a country where the care pathway of lung cancer patients, especially in terms of diagnosis and mortality, appears to be negatively affected by SEP level.
Identifiants
pubmed: 38849792
doi: 10.1186/s12889-024-19041-4
pii: 10.1186/s12889-024-19041-4
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1543Informations de copyright
© 2024. The Author(s).
Références
Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–22.
doi: 10.1016/S0140-6736(20)30925-9
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149:778–89.
doi: 10.1002/ijc.33588
AIOM. I numeri del cancro in Italia. Intermedia. 2022. https://www.aiom.it/wp-content/uploads/2022/12/2022_AIOM_NDC-web.pdf . Accessed 14 Sep 2023.
Malalasekera A, Nahm S, Blinman PL, Kao SC, Dhillon HM, Vardy JL. How long is too long? A scoping review of health system delays in lung cancer. Eur Respir Rev. 2018;27:180045.
pubmed: 30158277
pmcid: 9488868
doi: 10.1183/16000617.0045-2018
de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382:503–13.
pubmed: 31995683
doi: 10.1056/NEJMoa1911793
Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, et al. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol. 2019;30:1162–9.
pubmed: 30937431
pmcid: 6637372
doi: 10.1093/annonc/mdz117
National Lung Screening Trial Research Team. Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial. J Thorac Oncol. 2019;14:1732–42.
doi: 10.1016/j.jtho.2019.05.044
Burzic A, O’dowd EL, Baldwin DR. The future of lung cancer screening: current challenges and research priorities. Cancer Manag Res. 2022;14:637–45.
pubmed: 35210860
pmcid: 8859535
doi: 10.2147/CMAR.S293877
Tyczynski JE, Bray F, Parkin DM. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. Lancet Oncol. 2003;4:45–55.
pubmed: 12517539
doi: 10.1016/S1470-2045(03)00960-4
Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. Risk factors for lung cancer worldwide. Eur Respir J. 2016;48:889–902.
pubmed: 27174888
doi: 10.1183/13993003.00359-2016
Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Wspolczesna Onkologia. 2021;25:45–52.
pubmed: 33911981
pmcid: 8063897
doi: 10.5114/wo.2021.103829
Braveman P, Gottlieb L. The social determinants of health: it’s time to consider the causes of the causes. Public Health Rep. 2014;129:19–31.
pubmed: 24385661
pmcid: 3863696
doi: 10.1177/00333549141291S206
McMaughan DJ, Oloruntoba O, Smith ML. Socioeconomic status and access to healthcare: interrelated drivers for healthy aging. Frontiers. 2020;8:231.
Sosa E, D’Souza G, Akhtar A, Sur M, Love K, Duffels J, et al. Racial and socioeconomic disparities in lung cancer screening in the United States: a systematic review. CA Cancer J Clin. 2021;71:299–314.
pubmed: 34015860
pmcid: 8266751
doi: 10.3322/caac.21671
Castro S, Sosa E, Lozano V, Akhtar A, Love K, Duffels J, et al. The impact of income and education on lung cancer screening utilization, eligibility, and outcomes: a narrative review of socioeconomic disparities in lung cancer screening. J Thorac Dis. 2021;13:3745–57.
pubmed: 34277066
pmcid: 8264678
doi: 10.21037/jtd-20-3281
Singh GK, Jemal A. Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950–2014: over six decades of changing patterns and widening inequalities. J Environ Public Health. 2017;2017:2819372.
pubmed: 28408935
pmcid: 5376950
doi: 10.1155/2017/2819372
OECD. EU country cancer profile: Italy 2023. EU country cancer profiles. Paris: OECD Publishing; 2023. https://doi.org/10.1787/a0a66c1d-en .
Zhang X, Elsaid MI, DeGraffinreid C, Champion VL, Paskett ED, Brock G, et al. Impact of the COVID-19 pandemic on cancer screening delays. J Clin Oncol. 2023;41:3194–202.
pubmed: 36735899
doi: 10.1200/JCO.22.01704
Muka T, Li JJ, Farahani SJ, Pa Ioannidis J. An umbrella review of systematic reviews on the impact of the COVID-19 pandemic on cancer prevention and management, and patient needs. Elife. 2023;12:85679.
Cortinovis DL, Perrone V, Giacomini E, Sangiorgi D, Andretta M, Bartolini F, et al. Epidemiology, patients’ journey and healthcare costs in early-stage non-small-cell lung carcinoma: a real-world evidence analysis in Italy. Pharmaceuticals (Basel). 2023;16:363.
pubmed: 36986463
doi: 10.3390/ph16030363
Montedori A, Bidoli E, Serraino D, Fusco M, Giovannini G, Casucci P, et al. Accuracy of lung cancer ICD-9-CM codes in Umbria, Napoli 3 Sud and Friuli Venezia Giulia administrative healthcare databases: a diagnostic accuracy study. BMJ Open. 2018;8:e020628.
pubmed: 29773701
pmcid: 5961589
doi: 10.1136/bmjopen-2017-020628
Franchi M, Rea F, Santucci C, La Vecchia C, Boffetta P, Corrao G. Developing a multimorbidity prognostic score in elderly patients with solid cancer using administrative databases from Italy. Aging Cancer. 2021;2:98–104.
doi: 10.1002/aac2.12036
MacLean E, Louder A, Saverno K, Smith G, Mardekian J, Brunis C, et al. Molecular testing patterns in metastatic non-small cell lung cancer. Am J Manag Care. 2016;22:e60–7.
pubmed: 26881321
Braveman PA, Cubbin C, Egerter S, Williams DR, Pamuk E. Socioeconomic disparities in health in the United States: what the patterns tell us. Am J Public Health. 2010;100:S186–96.
pubmed: 20147693
pmcid: 2837459
doi: 10.2105/AJPH.2009.166082
Ventura M, Mataloni F, Colais P, Davoli M. Fusco D [More equity in Lazio region health care: results from the Regional Outcome Evaluation Program (PReValE), 2012–2017]. Epidemiol Prev. 2019;43:364–73.
pubmed: 31659884
Dipartimento di Epidemiologia del Servizio Sanitario Regionale del Lazio. Salute ed equità nella Regione Lazio. Roma: Il pensiero Scientifico Editore; 2022.
Caranci N, Biggeri A, Grisotto L, Pacelli B, Spadea T. Costa G [The Italian deprivation index at census block level: definition, description and association with general mortality]. Epidemiol Prev. 2010;34:167–76.
pubmed: 21224518
Rosano A, Pacelli B, Zengarini N, Costa G, Cislaghi C. Caranci N [Update and review of the 2011 Italian deprivation index calculated at the census section level]. Epidemiol Prev. 2020;44:162–70.
pubmed: 32631016
Cazzola M, Puxeddu E, Bettoncelli G, Novelli L, Segreti A, Cricelli C, et al. The prevalence of asthma and COPD in Italy: a practice-based study. Respir Med. 2011;105:386–91.
pubmed: 20951017
doi: 10.1016/j.rmed.2010.09.022
Shaya FT, Dongyi D, Akazawa MO, Blanchette CM, Wang J, Mapel DW, et al. Burden of concomitant asthma and COPD in a Medicaid population. Chest. 2008;134:14–9.
pubmed: 18339789
doi: 10.1378/chest.07-2317
AIFA. Innovative medicinal products. 2016. https://www.aifa.gov.it/en/farmaci-innovativi . Accessed 14 Sept 2023.
Matsuda A, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H, et al. Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2014;44:388–96.
pubmed: 24503029
doi: 10.1093/jjco/hyu003
Little AG, Gay EG, Gaspar LE, Stewart AK. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer. 2007;57:253–60.
pubmed: 17451842
doi: 10.1016/j.lungcan.2007.03.012
Morgensztern D, Ng SH, Gao F, Govindan R. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey. J Thorac Oncol. 2010;5:29–33.
pubmed: 19952801
doi: 10.1097/JTO.0b013e3181c5920c
Tamura T, Kurishima K, Nakazawa K, Kagohashi K, Ishikawa H, Satoh H, et al. Specific organ metastases and survival in metastatic non-small-cell lung cancer. Mol Clin Oncol. 2015;3:217–21.
pubmed: 25469298
doi: 10.3892/mco.2014.410
McPhail S, Swann R, Johnson SA, Barclay ME, Abd Elkader H, Alvi R, et al. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study. Lancet Oncol. 2022;23:587–600.
pubmed: 35397210
pmcid: 9046095
doi: 10.1016/S1470-2045(22)00127-9
Pollock AM, Vickers N. Deprivation and emergency admissions for cancers of colorectum, lung, and breast in south east England: ecological study. BMJ. 1998;317:245–52.
pubmed: 9677214
pmcid: 28615
doi: 10.1136/bmj.317.7153.245
Beckett P, Tata LJ, Hubbard RB. Risk factors and survival outcome for non-elective referral in non-small cell lung cancer patients - analysis based on the National Lung Cancer Audit. Lung Cancer. 2014;83:396–400.
pubmed: 24457105
doi: 10.1016/j.lungcan.2013.10.010
Raine R, Wong W, Scholes S, Ashton C, Obichere A, Ambler G. Social variations in access to hospital care for patients with colorectal, breast, and lung cancer between 1999 and 2006: Retrospective analysis of hospital episode statistics. BMJ. 2010;340:302.
doi: 10.1136/bmj.b5479
Zhou Y, Abel GA, Hamilton W, Pritchard-Jones K, Gross CP, Walter FM, et al. Diagnosis of cancer as an emergency: a critical review of current evidence. Nat Rev Clin Oncol. 2016;14:45–56.
pubmed: 27725680
doi: 10.1038/nrclinonc.2016.155
Meert AP, Sculier JP, Berghmans T. Lung cancer diagnosis in the emergency department. Eur Respir J. 2015;45:867–8.
pubmed: 25829427
doi: 10.1183/09031936.00198814
Walder JR, Faiz SA, Sandoval M. Lung cancer in the emergency department. Emerg Cancer Care. 2023;2:3.
pubmed: 38799792
pmcid: 11116267
doi: 10.1186/s44201-023-00018-9
Istituto Nazionale dei Tumori. Rete Italiana Screening Polmonare (RISP). 2022. https://programmarisp.it/ . Accessed 25 Oct 2023.
Scherpereel A, Durand-Zaleski I, Cotté FE, Fernandes J, Debieuvre D, Blein C, et al. Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study. BMC Cancer. 2018;18:1013.
pubmed: 30348130
pmcid: 6196460
doi: 10.1186/s12885-018-4958-5
Norris RP, Dew R, Greystoke A, Todd A, Sharp L. Socioeconomic inequalities in novel NSCLC treatments during the era of tumor biomarker-guided therapy: a population-based cohort study in a publicly funded health care system. J Thorac Oncol. 2023;18:990–1002.
pubmed: 37146751
doi: 10.1016/j.jtho.2023.04.018
Di Maio M, Signoriello S, Morabito A, Rossi A, Maione P, Piantedosi FV, et al. Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials. Lung Cancer. 2012;76:457–64.
pubmed: 22297086
doi: 10.1016/j.lungcan.2012.01.002
Hussain SK, Lenner P, Sundquist J, Hemminki K. Influence of education level on cancer survival in Sweden. Ann Oncol. 2008;19:156–62.
pubmed: 17785761
doi: 10.1093/annonc/mdm413
Johnson AM, Hines RB, Johnson JA, Bayakly AR. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence. Lung Cancer. 2014;83:401–7.
pubmed: 24491311
doi: 10.1016/j.lungcan.2014.01.008
Chang CM, Su YC, Lai NS, Huang KY, Chien SH, Chang YH, et al. The combined effect of individual and neighborhood socioeconomic status on cancer survival rates. PLoS One. 2012;7:e44325.
pubmed: 22957007
pmcid: 3431308
doi: 10.1371/journal.pone.0044325
Finke I, Behrens G, Schwettmann L, Gerken M, Pritzkuleit R, Holleczek B, et al. Socioeconomic differences and lung cancer survival in Germany: Investigation based on population-based clinical cancer registration. Lung Cancer. 2020;142:1–8.
pubmed: 32044589
doi: 10.1016/j.lungcan.2020.01.021
Chouaïd C, Debieuvre D, Durand-Zaleski I, Fernandes J, Scherpereel A, Westeel V, et al. Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study). PLoS One. 2017;12:e0182798.
pubmed: 28841679
pmcid: 5571949
doi: 10.1371/journal.pone.0182798
Pagano E, Filippini C, Di Cuonzo D, Ruffini E, Zanetti R, Rosso S, et al. Factors affecting pattern of care and survival in a population-based cohort of non-small-cell lung cancer incident cases. Cancer Epidemiol. 2010;34:483–9.
pubmed: 20444663
doi: 10.1016/j.canep.2010.04.002
Sayani A, Ali MA, Dey P, Corrado AM, Ziegler C, Nicholson E, et al. Interventions designed to increase the uptake of lung cancer screening: an equity-oriented scoping review. JTO Clin Res Rep. 2023;4:100469.
pubmed: 36938372
pmcid: 10015251
UN General Assembly. Transforming our world : the 2030 Agenda for Sustainable Development, 2015, A/RES/70/1. https://www.refworld.org/docid/57b6e3e44.html . Accessed 14 Sep 2023.
European Commission. European cancer inequalities registry. 2021. https://cancer-inequalities.jrc.ec.europa.eu/ . Accessed 14 Sep 2023.
Ministero della Salute. Piano Oncologico Nazionale: documento di pianificazione e indirizzo per la prevenzione e il contrasto del cancro 2023–2027. https://www.salute.gov.it/imgs/C_17_pubblicazioni_3291_allegato.pdf . Accessed 14 Sep 2023.
Pampel FC, Krueger PM, Denney JT. Socioeconomic disparities in health behaviors. Annu Rev Sociol. 2010;36:349–70.
pubmed: 21909182
pmcid: 3169799
doi: 10.1146/annurev.soc.012809.102529
Zajacova A, Lawrence EM. The relationship between education and health: reducing disparities through a contextual approach. Annu Rev Public Health. 2018;3:273–89.
doi: 10.1146/annurev-publhealth-031816-044628
Huisman M, Kunst AE, Mackenbach JP. Inequalities in the prevalence of smoking in the European Union: comparing education and income. Prev Med (Baltim). 2005;40:756–64.
doi: 10.1016/j.ypmed.2004.09.022
Egerter P, Braveman P, Sadegh-Nobari T, Grossman-Kahn R, Dekker M. Education and health. In: Exploring the social determinants of health. Princeton (NJ): Robert Wood Johnson Foundation; 2011.
Nante N, Messina G, Lispi L, Serafini A, Prisco G, Moirano F. Mobility trends of patients across Italian Regions: implications for planning and evaluation of hospital services. Ann Ig. 2016;28:328–38.
pubmed: 27627664
Nante N, Guarducci G, Lorenzini C, Messina G, Carle F, Carbone S, et al. Inter-regional hospital patients’ mobility in Italy. Healthcare (Switzerland). 2021;9:1182.
Balia S, Brau R, Marrocu E. Interregional patient mobility in a decentralized healthcare system. Reg Stud. 2018;52:388–402.
doi: 10.1080/00343404.2017.1307954